Chronic Venous Insufficiency
VeriGraft AB focuses on clinical research in chronic venous insufficiency, with attention to severe disease affecting venous function and lower-limb circulation. The sponsor’s work centers on patients with advanced venous disease and the restoration of impaired vein performance.
- Deep venous valve pathology
- Clinical signs and symptoms of CVI
- Severe chronic venous insufficiency
The research landscape is concentrated in Sweden and involves multiple collaborating sites, reflecting a focused therapeutic interest in treatment options for persistent venous dysfunction.
Tissue-Engineered Vein Replacement
The sponsor investigates personalized tissue-engineered veins and tissue-engineered blood vessels designed for venous reconstruction. This area of interest includes graft-based approaches intended to address structural and functional deficits in diseased veins.
- Personalized tissue-engineered veins
- Venous grafts with valves
- Blood vessel engineering
These studies place emphasis on regenerative vascular therapies for patients with chronic venous disorders.
Vascular Regeneration and Valve Function
VeriGraft AB’s clinical interests include restoration of venous valve function and improvement of vascular regeneration in the setting of chronic venous disease. The trials reflect a therapeutic focus on correcting valve-related pathology within the venous system.
- Venous valve restoration
- Valve-related venous pathology
- Reconstruction of diseased veins
This area links vascular surgery, regenerative medicine, and treatment of advanced venous insufficiency.
